Iroko   Report issue

For profit Phase 2 Phase 3
Founded: Philadelphia PA United States (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2009
NCT00964431
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Iroko Pharmaceuticals, LLC